IL10 and neoplasm: CpG oligodeoxynucleotides (CpG ODNs) emulate bacterial DNA and induce anti-tumor effects by activating the immune system when the immunosuppressive function of IL-10 is inhibited via targeting IL-10, IL-10R, or STAT3.